Nowadays, with the rapid popularization of Internet, more SMEs see the upgrade of network marketing after the economic crisis. In past economic crisis, the Internet industry has minimum impact in all industry, and more surprising is that the network economy accelerating develops. Today, more and more SMEs join network marketing, including the class of office furniture. The following is analysis of current situation of office furniture network marketing in China.
First: The office furniture industry has characteristics of many product varieties、more product quantity and big demand, so these factors led office furniture become more difficult in network promotion and network marketing, the workload is relatively large in the early.
Second: Different regions of China have different modes, and the gap is relatively large. Like coastal areas which started earlier so the development is faster, the mainland areas which started late so the development is not fast. If there is no perfect sales promotion strategy, the country's largest market is difficult to be integrated and resulting in a waste of resources.
Third: Office furniture is mainly targeted at large quantities order from enterprises and institutions, this kind of people rarely have habits that search related information in the Internet, they are more inclined to the traditional mode of shopping.
Fourth: When it comes to e-commerce is associated with good logistics. If you want to do good in e-commerce, without a good logistics service is impossible. It is more important for office furniture to have good logistics. Because the threshold of office furniture products is lower, and there are many manufacturers, and the market is mainly in the local. So if you want to develop overseas customers, you should take more consideration in the factory and logistics. Founding a high-quality logistics team for delivering the goods is very important.
Fifth: Office furniture product varieties are many, but the style and the color are single, it cannot meet the demand of individual people. Developers should make efforts for the development of new furniture; furniture product should follow the times form, and cater to most people's preferences. The supplier should gradual eliminate of outdated products on the market. As a business manager, should be forethought and grasp the biggest trends, so can achieve long-term development of enterprises.
LUOYANG REDSING CORPORATION (GROUP). Was established in 1986. The one of large comprehensive Metal Office Furniture supplier and manufacturer, gathering development、design、manufacture、and sale in it, can produce 6 series, more than 500 various products such as: China shoe rack、Machine mess-shelf、China office furniture、Book-shelf、File cabinet、Finance safe box、Office desk、School equipment and so on. Depend on its good quality, super after-sale service, the products selling well in domestic and Mongolia、Middle east、Russia、and Europe. Warmly welcome friends from home and abroad to our factory for a visit and negotiation for business with us.
How should companies choose the right furniture? When companies choose and purchase office furniture, they will consider more details. Because office furniture can affect the company's whole image, and choosing the right furniture is an important link to build excellent company. The following are some small details about purchasing office furniture.
The first point: selection of office furniture, the first step is measuring the area of the office. Because the different nature of the office, selection of office furniture size is not the same, Office furniture should be compact; layout should be reasonable; make full use of limited office space.
The second point: purchasing office furniture should pay attention to the appearance modeling. Because it can directly display the image of an enterprise, and it represents the taste and grade of the entire enterprise. Of course you don't necessarily purchase expensive office furniture, because it doesn’t mean it has grades and taste. Generally speaking, choosing the brand office furniture should be right, but it is not mean entirely correct. Grade office furniture should be suitable for development direction of the company, and left the impression of generous and comfortable to the customer.
The third point: should pay attention to the quality of office furniture at the time of purchasing. Good quality office furniture will reflect its intrinsic value. So when you purchase the office furniture, negotiating with the merchant is an important link. To find a way to get lower prices is a profound knowledge, and at the same time, you should sign a contract and After-sales service guarantee.
The fourth point: in the procurement of office furniture, some large companies may choose the higher brand office furniture; because they think it will highlight the position of their company. However, for the early establishment of the company, it is more important to choose the practical and fashionable office furniture of low price.
LUOYANG REDSING CORPORATION (GROUP). Was established in 1986. The one of large comprehensive Metal Office Furniture supplier and manufacturer, gathering development、design、manufacture、and sale in it, can produce 6 series, more than 500 various products such as: China shoe rack、Machine mess-shelf、China office furniture、Book-shelf、File cabinet、Finance safe box、Office desk、School equipment and so on. Depend on its good quality, super after-sale service, the products selling well in domestic and Mongolia、Middle east、Russia、and Europe. Warmly welcome friends from home and abroad to our factory for a visit and negotiation for business with us.
Over the years, because of foreign "green barriers", traditional Chinese medicine export repeatedly rebuffed. China as a traditional Chinese medicine major power, Chinese medicine export volume accounts only for 3% to 5% in the world's traditional Chinese medicine market. Even more worrying is that foreign pharmaceutical companies import medicinal extracts from China, and do further processing in abroad, then turn it into " foreign Chinese medicine "and resold in high price.
According to the statistical data of China Chamber of Commerce for import and export of medicines and health products to display, plant extracts exports reached $330 million in the first quarter of 2013, an increase of 11.2%, accounting for 47% of the Chinese traditional medicine merchandise exports. Plant extracts in China export volume increasing year by year, it was $820 million in 2010, $1 billion in 2011, and reach to $1.16 billion in 2012. These plant extracts is processed into higher value-added "foreign Chinese medicine", and most of them were sold to the world's largest Chinese medicine consumption country -- China.
According to media reports, Jiuxindan is made in Japan Pharmaceutical Co. Ltd. , and it is developed on the basis of traditional Chinese medicine, and have implemented hundreds of millions of dollars a year in sales. The vast majority of those sales come from China. Germany imports large quantities of cheap ginkgo biloba from China every year, and then sold back to China in a higher price. According to incomplete statistics, "foreign Chinese medicine" has accounted for a third of the proprietary Chinese medicine market in China.
Due to successful experience of Japan Jiuxin Pharmaceutical Co. Ltd., more and more multinational companies are looking for the opportunities of traditional Chinese medicine to develop and invest. At the beginning of this year, the British FMCG giant Reckitt has announced the acquisition of Chinese medicine traditional Chinese medicine enterprises GuiLong.
Traditional Chinese medicine industry has been the traditional advantage industry in China, it has a long history of several thousand years, and it is the treasure of the Chinese nation. Over the years, traditional Chinese medicine traditional Chinese medicine with its yield, wide distribution, small toxic and side effect and other advantages occupy half of China's pharmaceutical industry. On the other hand, China lack of emphasis on traditional Chinese medicine industry. And traditional Chinese medicine industry technical standard system is not perfect, resulting in the slow development of traditional Chinese medicine industry and the internationalization of traditional Chinese medicine is difficult.
Rongda Pharm & Chem Co., Ltd is mainly involving in development, production and sales of pharm chemicals, fine chemicals, pharma intermediates, supplemented with AGRO chemicals. With the principle of 'to be honest, quality first, credit as our life”, we strive to make contributions to China pharm. And we will always try our best to provide our customer first class product. Warmly welcome friends from both home and abroad to cooperate with us.
According to The 20132017 Report of Demand and Supply and Competition in API market of Chinese Pharmaceutical Industry, the export of Chinese API was $12,112 thousand during the first half year of 2013, increasing by 3.08% and the accurate amount was 3,339.3 million tons, increasing by 7.46%. While the average export price decreased by 4.07%, the increasing rate was still low.
Nowadays, as the oversupply and the fierce competition in the market, as well as the slow economy recovery in developed countries and the currency devaluation in emerging market countries, it was hard to increase the export price of API. However, the growing cost of various aspects left little space for price decreasing.
One of the possible reasons for the oversupply of API was low demanding in technical request，easy to copy and no difference between products. Especially in the improvement of new GMP, it was easily to get to the point of oversupply of relatively low-tech products because of the fast investment in fixed assets. Thus decreasing the whole profit and causing vicious competition within the industry.
Another main reason to profit decreasing was a lack of capacity to solve environmental cost, especially with its rapid growth requirement. On one hand, all the cost was increasing. On the other hand, the price of terminal medicines was going down continuously, which brought about big difficulties to API firms. Moreover, the appreciation of the RMB also put stress on the export of API manufacturing and intermediate products with relatively low additional value.
Facing the depressed export market, pharmaceutical industry claimed to make effort to explore international market. Emphasis should be put on enlarging international market shares, participating in regional economic and trade cooperation actively, and finding solutions to various problems. Further, it should catch the opportunity to this new round of global pharmaceutical industry shift to Asian and enhance the transfer and absorption ability of global pharmaceutical industry.
Additionally, as the statistics showed: the export of Chinese API to emerging markets increased by 10.03%. Among this, large and medium pharmaceutical firms aimed to explore emerging and African markets greatly and the number of top pharmaceutical firms exporting to emerging markets increased by 12.2%. Under this fragile global economic and low demand of medicines circumstance, emerging markets was almost the only aim to Chinese API export.
Rongda Pharm & Chem Co., Ltd is mainly involving in development, production and sales of pharm chemicals, fine chemicals, pharma intermediates, supplemented with AGRO chemicals. With the principle of 'to be honest, quality first, credit as our life”, we strive to make contributions to China pharm. And we will always try our best to provide our customer first class product. Warmly welcome friends from both home and abroad to cooperate with us.
In recent years, China's BPC industry has developed rapidly and China has become the world's largest BPC producer and exporter. Currently, the foreign trade is still at the stage of constant growth with promising prospect. The constant progress of new medical system reform and supporting measures has promoted the industrial structure change of China's pharmaceutical manufacturing industry, which brings great opportunities for China's pharmaceutical industry. The prosperous industrial development provides favorable development opportunity for "CPhI, ICSE & BioPh China".
The exhibition will gather the most cutting-edge information of the pharmaceutical markets and present a comprehensive one-stop pharmaceutical industry trade platform for over 2,500 exhibitors and over 40,000 professional purchasers coming from more than 20 countries.
The meeting adopts the form of "display-meeting" to make the world timely grasp the latest news of Chinese and global pharmaceutical markets and create opportunities for further developing markets. In order to better promote the information interaction between the audience and enterprises, and satisfy the demand of the audience and enterprises for the latest industrial information and technological exchanges, the organizer during the exhibition will meticulously plan high-end forum, professional seminar, technological exchange symposium among exhibitors and purchase matching and other activities in terms of domestic and international latest policies, regulations, hot topics of the industry and practical technology application.
In order to protect IPR, the organizer will screen the product catalogue of all participating companies before the exhibition, forbid enterprises with infringing products to participate and protect the image of "Made in China" on the international stage. During the exhibition, it will establish exhibition intellectual property office on the site together with Shanghai Intellectual Property Administration to receive the complaints from the owners of intellectual property and deal with relevant matters. Meanwhile, the organizer will work with the drug supervision and administration department to conduct random check on the quality of on-spot exhibits.
At present, China Chamber of Commerce has formulated work solutions for resisting illegal drugs. It plans to use the exhibition platform to resist and crack down on illegal behaviors in partnership with the national drug supervision and administration department so as to maintain the industrial image and normal operation order.
Rongda Pharm & Chem Co., Ltd is mainly involving in development, production and sales of pharm chemicals, fine chemicals, pharma intermediates, supplemented with AGRO chemicals. With the principle of 'to be honest, quality first, credit as our life”, we strive to make contributions to China pharm. And we will always try our best to provide our customer first class product. Warmly welcome friends from both home and abroad to cooperate with us.
In recent years, with the continuous development of the pharmaceutical industry, the pharmaceutical trade export has become a focus of concern to the industry. Export trade appeared serious polarization, the developed market remains in the doldrums, and the demand of emerging market is strong.
According to relevant statistics show that the first half of this year the number of China's pharmaceutical products export to Europe and the United States, Japan and other developed markets is growth of 3.27%. It accounted for 55.26 percent export market share and compared with the same period last year decreased by 2 percentage points. A long-term double-digit growth of China pharm dressing export is end, and up only slightly by 1.01 percent. Currently, from basic data analysis: China's medical dressing industry as a whole showed the characteristics is small market size and product homogeneity; the industry concentration degree is low; the value-added is not high. Along with market competition heats up, the enterprise competition is mainly concentrated in terms of price competition, and the industry is in the low level competition stage.
However, the characteristic API exports increased rapidly, and formulations exports will usher in rapid growth period. According to incomplete statistics, in the first half, China's characteristic API exported $1.067 billion, up 11.23% from a year earlier. And exporting to India, the United States, the European Union, Japan and South Korea mainly accounted for more than 80% of the market. The first half of the year, western medicine preparation exported USD $ 1357000000, up 7.93% from a year earlier. The pharmaceutical preparations exports is expected would usher in a new period of rapid growth in the second half of this year.
In the export trade rising market, the momentum of Chinese medicine export increase is the most rapid. Exports amounted to $ 491 million, up 22.49%. These increases were mainly from exports of Chinese herbal medicine and extracts increased significantly. Among them, the domestic prices of Chinese herbal medicine are continuous rise in the past two years, and last year international customers reduced the purchase quantity, especially in Japan and South Korea and the ASEAN customers. Resulting in a decline in inventories in the first half of this year, which in turn increase the purchase quantity, and it will stimulate the prices are further increases at the same time. The first half of the year, Chinese export prices and export volume compared with the same period last year increased by 30.44%, 8.24%. it is expected that it will continue to maintain this favorable situation in the second half.
Many domestic pharmaceutical companies optimistic about this situation, choose the right direction, and prepare to enter the field. And further optimize the export structure, effectively stimulating the export of Chinese medicine products to further growth.
Rongda Pharm & Chem Co., Ltd is mainly involving in development, production and sales of pharm chemicals, fine chemicals, pharma intermediates, supplemented with AGRO chemicals. With the principle of 'to be honest, quality first, credit as our life”, we will always try our best to provide our customer first class product. Warmly welcome friends from both home and abroad to cooperate with us.
As a major exporter of API, China encountered many difficulties in entering the market in Europe and the United States. Recently, China Chamber of Commerce for Import of Medicine &Health Products (Hereinafter referred to as CCCMHPIE) introduced: the first half of the year, China's pharmaceutical import and export trade amounted to USD $43.237 billion. It’s Up 10.28% from a year earlier. But since the third quarter, China's API export to Europe and the United States perhaps will into the most difficult period. In the first half of this year, the global economic growth momentum is insufficient; the international market demand has not been radically improved, leading to the international pharmaceutical trade volume decreased. Against this background, the development situation of China pharm foreign trade is more severe. It is embodied as prominent overcapacity contradictions, the downward pressure of economy increased, Sluggish external demand and rising costs, increasing trade friction and so on. Meanwhile, the vice president of CCCMHPIE Xu Ming also admitted that China's pharmaceutical trades probably enter to a relatively long complicated period in the second half of this year. And the unstable and uncertain factors will increase. Especially the traditional API market in Europe and the United States nearly saturated, and the prices are low. When the market demand in Europe and the United States is still difficult to have markedly improved, China's API export to Europe and the United States perhaps will into the most difficult period CCCMHPIE analysis, the recent main characteristics of China's pharmaceutical trade is: The developed market remains in the doldrums; strong emerging market demand ; export structure was further optimized; export transformation tension is growth; medical equipment and characteristic API increased sharply; Cost advantage declines; weaken the market competitiveness of medical dressings and disposable supplies. ‘Against such a backdrop, Emerging markets become China's API exports increment the only way.’ Xu Ming said. Data show that the first half of China’s API exports to emerging markets increased 10.03%. Among them, the medium-sized pharmaceutical enterprises to increase efforts to develop emerging markets and African markets. The number of top 100 pharmaceutical enterprises exports to emerging markets is increased by 12.2%. Rongda Pharm & Chem Co., Ltd is mainly involving in development, production and sales of pharm chemicals, fine chemicals, pharma intermediates, supplemented with AGRO chemicals. With the principle of 'to be honest, quality first, credit as our life”, we will always try our best to provide our customer first class product.Warmly welcome friends from both home and abroad to cooperate with us.
Maybe everyone will have a lot of jeans in their wardrobes, jeans for many people are not just a piece of clothing, but also are collections. Therefore, it is very important to maintain and wash jeans in a correct way. The following introduction is about the proper maintenance and washing of jeans.
You'd better not wear jeans over three days, because it will be deformation if you wear it for a long time. But it does not mean the jeans should be washed once every three days
Hang it in a well ventilated place, it not only can remove the sweat of the jeans, but also can let fabric fiber to restore natural. Jeans in general should be washing once every 1-3 months, or even longer. Frequent cleaning will cause deformation and decolorization on jeans. In summer, when you sweat a lot, you can sprinkle some water on your ladies pants, and use a wet towel to wipe down fabric direction so that you can wipe off the dust and dirt. Then hang them in a well ventilated place.
Jeans need to have color processing when you wash it in the first time. If you add some white vinegar or salt in the water to soak for an hour or more, the jeans won’t seriously fade. When washing jeans first to check is there any place has obvious besmirch, if it has, you can gently rub it off with your hand. Remember don’t use brush. Then zip up the zipper in cause the jeans will be deformed in washing process. Then wash the jeans inside out with hands or washing machine, and avoid making jeans worn and faded. Do not use hot water to wash otherwise the ladies pants will shrink. The water temperature on 30 degrees is fit. Do not use too much washing powder. It is best to use a mild detergent, and then the jeans will not become stiff. To avoid sun exposure, otherwise it will cause oxidative color fading or hardening.
Guangzhou Yong-jia Garment Manufacturing Co., Ltd. is a Guangzhou based clothing manufacturer. We specialize in ladies pant , jeans and jackets in a wide assortment of fabrics. We have high quality products and offer many kinds of products for customers, such as ladies short, maternity pant and kids pant. So if you have any need, please feel free to visit our website http://www.yongjia-jeans.com/
2013 Denim Innovation Forum held at Guangzhou Shangri-La Hotel on August 7.The theme of this forum is LET DENIM GO GREEN. This forum mainly investigated the denim industry of environmental protection and sustainable development, and hosted by the Dr. Lin Jiang from Lingnan College of Zhongshan University. Speakers were jointly analyzed the current situation of the denim industry, especially on environmental pollution problems. They also shared the various enterprises’ technology and experience of environmental protection and sustainable development, particularly in the technology of environmental fibers, dyes and laser washing.
"It was not planned, we just launched the action." the planners of 2013 Denim Innovation Forum Qin Gang said. Indeed, there are many textile industry forums each year including denim, but the real influence in the industry forum is not much, can drive the industry to change even less.
In nearly four hours after the end of the forum, the Beijiang textiles also invited all the guests watched a very powerful magic denim show, this fashion show with the theme of the tropical rainforest ,used vivid and stylish form to interpreted environmental and technological of denim. The next day, the Forum guests also visited Guangzhou Textile Trading Park and participated in a professional seminars which is used laser technology instead of the traditional denim washing
Denim Innovation Forum in its pragmatic form and pattern of international forums, as well as the characteristics of seamless docking between supply chain and brand retailers, left a deep impression on us. Let us see the future direction of the industry. Meanwhile, the Beijiang textile as an excellent Chinese denim fabric business has been walking the road of innovation and development. This time, Beijiang textile and the supply chain of upstream enterprises from all over the world, jointly held denim innovation forum to promote the denim industry's environmental and sustainable development! This really reflects their strong ability to integrate resources, as well as bold and innovative courage!
Guangzhou Yong-jia Garment Manufacturing Co., Ltd, is a Guangzhou based clothing manufacturer. We specialize in ladies pant , jeans and jackets in a wide assortment of fabrics. We have high quality products and offer many kinds of products for customers, such as ladies capri pants, ladies short and kids capri. So if you have any need, please feel free to visit our website http://www.yongjia-jeans.com/
In the September 16, 2013 annual meeting of China Denim apparel meeting came to an end in Wuhan Textile University. Experts、scholars and Enterprises from all over China to explore the current situation and development trend of denim clothing industry. The annual meeting organized by the China Textile Industry Association and Held by Wuhan Textile University. The theme of this annual forum is "ecological, environmental, health, fashion". The vice president of China Textile Industry federation Yang Ji-Chao made a report entitled status and development prospects of China's textile industry. Chairman of China Textile Industry Association Zhu Beina made a speech and read the award-winning papers and fabrics enterprise. Experts at the meeting introduced the trends and market analysis of jeans, and participants felt refreshing about denim innovation forum. The annual output of Chinese jeans is about 4.8 billion jeans, has been ranked first in the world. Reporter learned that, Shandong, Jiangsu, Zhejiang, Guangdong and other coastal provinces has become the development gathering place of denim industry, swept almost ninety percent of the national production. Wuhan textile university professor Yi Changhai introduced that there are four big denim industrial clusters. There are more than 4300 denim enterprises in Zengcheng Xintang, Foshan Junan denim enterprises more than 2300; Zhongshan and Kaiping are respectively about 2000 denim enterprises. Yi Chang-Hai said denim has the longest process in all clothing category, including pulp dyeing, weaving, finishing, garment, washing and so on. At the meeting, Hubei Province Textile Industry Association, Wang Zhang introduced the economic operation of Hubei textile industry about last year and the first half year. At present, the production capacity of hubei province is 25 billion tons, 7,000,000,000 meters of fabric, one billion garments, 150 million meters of printing and dyeing cloth in , but the profitability of the cotton spinning industry compare with some developed coastal provinces there is a big gap. The annual meeting was held in Hubei will bring new opportunities for industrial development. Now, Coastal denim industry is facing the unfavorable situation of rising labor costs, the decline in exports, Domestic sales will be a big trend. In this context, Hubei close to raw materials location of cotton, cotton yarn , so the labor cost advantages are obvious, plus transportation advantages of nine provinces of , is ideal for coastal denim enterprises have moved to undertake. Guangzhou Yong-jia Garment Manufacturing Co., Ltd, is a Guangzhou based clothing manufacturer. We specialize in ladies pant , jeans and jackets in a wide assortment of fabrics. We have high quality products and offer many kinds of products for customers, such as ladies short, maternity pant and kids pant. So if you have any need, please feel free to visit our website http://www.yongjia-jeans.com/
|
RSS Feed